Relevium’s first acquisition is a patented technology that helps the recovery process from injuries by improving circulation and reducing pain. Relevium will focus on the development and commercialization of magnetic technology for use in therapeutic devices to assist in the recovery and healing process from injuries in muscles, ligaments and tendons.
In addition to leveraging Relevium’s patented technology, the company plans to focus and consolidate businesses in three key specific businesses: Nutraceuticals, Wearables and Services, all in keeping with its strategic focus in Pain, Recovery and Performance. In terms of the acquisition and delivery of products, Relevium will have a strong focus on E-Retail assets while continuing to develop an exclusive brick and mortar distribution network.
Relevium Technologies Inc. (TSXV:RLV) is a featured sponsored company and has paid SmallCapPower.com a fee for coverage. To learn more, see our full disclosure HERE >>